Walter A. Kukull
#127,144
Most Influential Person Now
Researcher
Walter A. Kukull's AcademicInfluence.com Rankings
Walter A. Kukullphilosophy Degrees
Philosophy
#6006
World Rank
#8964
Historical Rank
Logic
#3200
World Rank
#4321
Historical Rank

Download Badge
Philosophy
Walter A. Kukull's Degrees
- PhD Epidemiology University of Washington
- Masters Biostatistics University of Washington
- Bachelors Biology University of Washington
Similar Degrees You Can Earn
Why Is Walter A. Kukull Influential?
(Suggest an Edit or Addition)Walter A. Kukull's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease (2013) (3484)
- Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease: A Meta-analysis (1997) (3245)
- Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. (1997) (2488)
- Secreted amyloid β–protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease (1996) (2328)
- Common variants in MS4A4/MS4A6E, CD2uAP, CD33, and EPHA1 are associated with late-onset Alzheimer’s disease (2011) (1656)
- Diagnosis and management of dementia with Lewy bodies (2017) (1606)
- Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature (2012) (1494)
- Analysis of shared heritability in common disorders of the brain (2016) (1385)
- Exercise Is Associated with Reduced Risk for Incident Dementia among Persons 65 Years of Age and Older (2006) (1238)
- Gene-Wide Analysis Detects Two New Susceptibility Genes for Alzheimer's Disease (2014) (1230)
- Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (2019) (1073)
- Primary age-related tauopathy (PART): a common pathology associated with human aging (2014) (988)
- The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) (1994) (924)
- Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. (1996) (884)
- Accuracy of the Clinical Diagnosis of Alzheimer Disease at National Institute on Aging Alzheimer Disease Centers, 2005–2010 (2012) (793)
- Exercise plus behavioral management in patients with Alzheimer disease: a randomized controlled trial. (2003) (784)
- Dementia and Alzheimer disease incidence: a prospective cohort study. (2002) (726)
- The Uniform Data Set (UDS): Clinical and Cognitive Variables and Descriptive Data From Alzheimer Disease Centers (2006) (704)
- Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease (2017) (693)
- Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report (2019) (646)
- Neuropathology of nondemented aging: Presumptive evidence for preclinical Alzheimer disease (2009) (621)
- The Alzheimer's Disease Centers' Uniform Data Set (UDS): The Neuropsychologic Test Battery (2009) (588)
- Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer's Coordinating Centre. (2013) (572)
- Depression as a risk factor for Alzheimer disease: the MIRAGE Study. (2003) (524)
- The National Alzheimer's Coordinating Center (NACC) Database: The Uniform Data Set (2007) (506)
- Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons (2008) (486)
- Head injury and the risk of AD in the MIRAGE study (2000) (456)
- GAB2 Alleles Modify Alzheimer's Risk in APOE ɛ4 Carriers (2007) (452)
- Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes. (2010) (426)
- Interactions of apolipoprotein E genotype, total cholesterol level, age, and sex in prediction of Alzheimer's disease (1995) (392)
- National estimates of the prevalence of Alzheimer’s disease in the United States (2011) (365)
- Apolipoprotein E Genotype and Sex Risk Factors for Alzheimer Disease: A Meta-analysis (2017) (363)
- Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E ϵ4,and the risk of late-onset Alzheimer disease in African Americans. (2013) (345)
- Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis (2017) (329)
- Adverse drug reactions associated with global cognitive impairment in elderly persons. (1987) (316)
- Common genetic variants in the CLDN2 and PRSS1-PRSS2 loci alter risk for alcohol-related and sporadic pancreatitis (2012) (308)
- Postmenopausal estrogen replacement therapy and the risk of Alzheimer's disease: a population-based case-control study. (1994) (308)
- Progression to dementia in patients with isolated memory loss (1997) (303)
- Genome-Wide Association Meta-analysis of Neuropathologic Features of Alzheimer's Disease and Related Dementias (2014) (295)
- Risk of dementia among relatives of Alzheimer's disease patients in the MIRAGE study (1996) (288)
- The Mini-Mental State Examination score and the clinical diagnosis of dementia. (1994) (283)
- APOE ε4 increases risk for dementia in pure synucleinopathies. (2013) (282)
- GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers. (2007) (277)
- Genetic assessment of age-associated Alzheimer disease risk: Development and validation of a polygenic hazard score (2017) (277)
- Common variants at MS 4 A 4 / MS 4 A 6 E , CD 2 AP , CD 33 and EPHA 1 are associated with late-onset Alzheimer ’ s disease (2011) (274)
- Altered neuronal gene expression in brain regions differentially affected by Alzheimer's disease: a reference data set. (2008) (258)
- The National Alzheimer's Coordinating Center (NACC) Database: An Alzheimer Disease Database (2004) (249)
- Gene expression profiles in anatomically and functionally distinct regions of the normal aged human brain. (2007) (247)
- New insights into the genetic etiology of Alzheimer’s disease and related dementias (2022) (246)
- A NOVEL ALZHEIMER DISEASE LOCUS LOCATED NEAR THE GENE ENCODING TAU PROTEIN (2015) (246)
- Mutations in COQ2 in familial and sporadic multiple-system atrophy. (2013) (246)
- Cognitive differences in dementia patients with autopsy-verified AD, Lewy body pathology, or both (2005) (244)
- Version 3 of the Alzheimer Disease Centers’ Neuropsychological Test Battery in the Uniform Data Set (UDS) (2017) (236)
- History of Depression as a Risk Factor for Alzheimer's Disease (1995) (233)
- Survival after Initial Diagnosis of Alzheimer Disease (2004) (224)
- Characteristics of Sleep Disturbance in Community-Dwelling Alzheimer's Disease Patients (1999) (216)
- Subjective Memory Deterioration and Future Dementia in People Aged 65 and Older (2004) (213)
- Anxiety of Alzheimer's disease: prevalence, and comorbidity. (1999) (202)
- Exceptionally low likelihood of Alzheimer’s dementia in APOE2 homozygotes from a 5,000-person neuropathological study (2019) (194)
- Outcome-Based Doctor-Patient Interaction Analysis: II. Identifying Effective Provider and Patient Behavior (1982) (192)
- Outcome-Based Doctor-Patient Interaction Analysis: I. Comparison of Techniques (1982) (191)
- Relationship between cigarette smoking and Alzheimer's disease in a population‐based case‐control study (1992) (189)
- Sex-Specific Association of Apolipoprotein E With Cerebrospinal Fluid Levels of Tau (2018) (186)
- Epidemiology of dementia: concepts and overview. (2000) (185)
- Early-life risk factors and the development of Alzheimer’s disease (2000) (182)
- Cognitive decline in Alzheimer's disease: a longitudinal investigation of risk factors for accelerated decline. (1995) (181)
- Footwear Style and Risk of Falls in Older Adults (2004) (178)
- Head injury and risk of Alzheimer's disease by apolipoprotein E genotype. (1997) (172)
- Statin therapy and risk of dementia in the elderly (2004) (172)
- Convergent genetic and expression data implicate immunity in Alzheimer's disease (2014) (172)
- Generalizability: the trees, the forest, and the low-hanging fruit. (2012) (168)
- Biomechanical Properties of Shoes and Risk of Falls in Older Adults (2004) (165)
- The validity of 3 clinical diagnostic criteria for Alzheimer's disease (1990) (164)
- Symptomatic Depression in Elderly Medical Outpatients (1986) (161)
- Gene expression correlates of neurofibrillary tangles in Alzheimer's disease (2006) (159)
- Cognitive impairment: dementia and Alzheimer's disease. (1992) (158)
- Version 3 of the National Alzheimer’s Coordinating Center’s Uniform Data Set (2018) (154)
- Symptom Patterns and Comorbidity in the Early Stages of Alzheimer's Disease (1994) (149)
- Transethnic genome-wide scan identifies novel Alzheimer's disease loci (2017) (149)
- Nonsteroidal anti‐inflammatory drugs and risk of Parkinson's disease (2006) (142)
- Accelerated decline in apolipoprotein E-ϵ4 homozygotes with Alzheimer's disease (1998) (141)
- Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study. (2014) (140)
- GBA mutations increase risk for Lewy body disease with and without Alzheimer disease pathology (2012) (135)
- Clinical and neuropathological characteristics of hippocampal sclerosis: a community-based study. (2002) (132)
- Atherosclerosis and AD (2005) (131)
- “New Old Pathologies”: AD, PART, and Cerebral Age-Related TDP-43 With Sclerosis (CARTS) (2016) (123)
- Using Census Data and Birth Certificates to Reconstruct the Early-Life Socioeconomic Environment and the Relation to the Development of Alzheimer’s Disease (2001) (123)
- Predictors of mortality in patients diagnosed with probable Alzheimer's disease (1996) (121)
- Body Mass Index, Weight Change, and Clinical Progression in Mild Cognitive Impairment and Alzheimer Disease (2014) (120)
- Solvent exposure as a risk factor for Alzheimer's disease: a case-control study. (1995) (116)
- Serum cholesterol and risk of Alzheimer disease (2005) (112)
- Age‐Varying Association Between Blood Pressure and Risk of Dementia in Those Aged 65 and Older: A Community‐Based Prospective Cohort Study (2007) (109)
- Wandering: a significant problem among community-residing individuals with Alzheimer's disease. (1998) (108)
- The Alzheimer ’ s Disease Centers ’ Uniform Data Set ( UDS ) : The Neuropsychological Test Battery (2009) (107)
- RESEARCH ARTICLE: Empiric Refinement of the Pathologic Assessment of Lewy‐Related Pathology in the Dementia Patient (2008) (107)
- Education, cognitive function, and severity of neuropathology in Alzheimer disease (2008) (106)
- Neighborhood Environment and Cognition in Older Adults: A Systematic Review. (2017) (102)
- Exercise and activity level in Alzheimer's disease: a potential treatment focus. (1998) (101)
- Age‐Varying Association Between Statin Use and Incident Alzheimer's Disease (2010) (101)
- Cerebral amyloid angiopathy and its co-occurrence with Alzheimer's disease and other cerebrovascular neuropathologic changes (2015) (100)
- Alzheimer disease pathology in cognitively healthy elderly: A genome-wide study (2011) (100)
- Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture (2021) (99)
- Interrater reliability of Alzheimer's disease diagnosis (1990) (98)
- Variants associated with Gaucher disease in multiple system atrophy (2015) (97)
- Depression and physical illness among elderly general medical clinic patients. (1986) (96)
- APP717, APP693, and PRIP gene mutations are rare in Alzheimer disease. (1991) (95)
- Arteriolosclerosis that affects multiple brain regions is linked to hippocampal sclerosis of ageing. (2014) (95)
- Two rare AKAP9 variants are associated with Alzheimer's disease in African Americans (2014) (92)
- The apolipoprotein E/CI/CII gene cluster and late-onset Alzheimer disease. (1994) (90)
- Causes of Death Associated with Alzheimer Disease: Variation by Level of Cognitive Impairment Before Death (1994) (90)
- The Revised National Alzheimer’s Coordinating Center’s Neuropathology Form—Available Data and New Analyses (2018) (89)
- Accelerated decline in apolipoprotein E-epsilon4 homozygotes with Alzheimer's disease. (1998) (89)
- Novel Alzheimer Disease Risk Loci and Pathways in African American Individuals Using the African Genome Resources Panel: A Meta-analysis. (2020) (86)
- Tumor necrosis factor α and interleukin 10 promoter region polymorphisms and risk of late-onset Alzheimer disease (2006) (85)
- Hippocampal sclerosis of aging is a key Alzheimer's disease mimic: clinical-pathologic correlations and comparisons with both alzheimer's disease and non-tauopathic frontotemporal lobar degeneration. (2014) (83)
- Dementia epidemiology. (2002) (83)
- History of head trauma and risk of intracranial meningioma: Population-based case-control study (2002) (82)
- Symptom Distress, Psychosocial Variables, and Survival From Lung Cancer (1986) (81)
- The North American Multiple System Atrophy Study Group (2005) (80)
- Anxiety Symptoms as Predictors of Nursing Home Placement in Patients with Alzheimer's Disease (2002) (80)
- A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity (2019) (77)
- Results From the NACC Uniform Data Set Neuropsychological Battery Crosswalk Study (2016) (75)
- Atherosclerosis and AD: analysis of data from the US National Alzheimer's Coordinating Center. (2005) (75)
- Mixed neuropathologies and estimated rates of clinical progression in a large autopsy sample (2017) (74)
- Sleep Disturbance in Dementia with Lewy Bodies and Alzheimer’s Disease: A Multicenter Analysis (2011) (74)
- Multisite assessment of NIA-AA guidelines for the neuropathologic evaluation of Alzheimer's disease (2016) (73)
- Neuronal gene expression in non-demented individuals with intermediate Alzheimer's Disease neuropathology (2010) (73)
- ABCC9 gene polymorphism is associated with hippocampal sclerosis of aging pathology (2014) (72)
- Characterizing Apolipoprotein E ε4 Carriers and Noncarriers With the Clinical Diagnosis of Mild to Moderate Alzheimer Dementia and Minimal β-Amyloid Peptide Plaques. (2015) (71)
- Risk factors and global cognitive status related to brain arteriolosclerosis in elderly individuals (2017) (70)
- The cognitive abilities screening instrument (CASI): data from a cohort of 2524 cognitively intact elderly (1999) (70)
- The human FE65 gene: genomic structure and an intronic biallelic polymorphism associated with sporadic dementia of the Alzheimer type (1998) (70)
- Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans (2017) (67)
- Dementia registries around the globe and their applications: A systematic review (2017) (66)
- Neuropsychological changes in asymptomatic persons with Alzheimer disease neuropathology (2014) (66)
- University of Washington Alzheimer’s Disease Patient Registry (ADPR): 1987–8 (1990) (66)
- 2014 Report on the Milestones for the US National Plan to Address Alzheimer's Disease (2014) (65)
- Drinking water aluminum and bioavailability (1995) (64)
- Impact of Sample Selection on APOE ∈4 Allele Frequency: A Comparison of Two Alzheimer's Disease Samples (1996) (63)
- Neuropathologic differences by race from the National Alzheimer's Coordinating Center (2016) (63)
- Healthcare Utilization and Costs in Managed Care Patients with Alzheimer's Disease During the Last Few Years of Life (2001) (62)
- Alzheimer's disease neuropathologic change, Lewy body disease, and vascular brain injury in clinic- and community-based samples (2017) (61)
- Associations between depression, sleep disturbance, and apolipoprotein E in the development of Alzheimer's disease: dementia (2016) (60)
- Associations Between Microinfarcts and Other Macroscopic Vascular Findings on Neuropathologic Examination in 2 Databases (2009) (58)
- Apolipoprotein E in Alzheimer's disease risk and case detection: a case-control study. (1996) (57)
- Utility of the global CDR® plus NACC FTLD rating and development of scoring rules: Data from the ARTFL/LEFFTDS Consortium (2020) (56)
- Shared genetic contribution to ischemic stroke and Alzheimer's disease (2016) (55)
- Polygenic hazard score, amyloid deposition and Alzheimer’s neurodegeneration (2019) (53)
- The association between smoking and Alzheimer’s disease: effects of study design and bias (2001) (53)
- Rapid eye movement sleep measures of Alzheimer's-type dementia patients and optimally healthy aged individuals. (1984) (53)
- Sex differences in the genetic predictors of Alzheimer's pathology. (2019) (51)
- Comparison of symptomatic and asymptomatic persons with Alzheimer disease neuropathology (2013) (50)
- Reassessment of Risk Genotypes (GRN, TMEM106B, and ABCC9 Variants) Associated With Hippocampal Sclerosis of Aging Pathology (2015) (49)
- Generalizability (2012) (47)
- Physical activity and subarachnoid haemorrhage: a population based case-control study (2000) (46)
- Polygenic hazard scores in preclinical Alzheimer’s disease (2017) (45)
- Association between enrollment factors and incident cognitive impairment in Blacks and Whites: Data from the Alzheimer's Disease Center (2019) (45)
- Tumor necrosis factor alpha and interleukin 10 promoter region polymorphisms and risk of late-onset Alzheimer disease. (2006) (45)
- Age-at-Onset in Late Onset Alzheimer Disease is Modified by Multiple Genetic Loci (2014) (44)
- Interrater agreement for diagnosis of Alzheimer's disease (1994) (44)
- Age‐dependent effects of APOE ε4 in preclinical Alzheimer's disease (2016) (43)
- Duration and Pathologic Correlates of Lewy Body Disease (2017) (43)
- Medical complications of ischemic stroke and length of hospital stay: experience in Seattle, Washington. (1999) (43)
- Thinking Outside the Box: Alzheimer-Type Neuropathology That Does Not Map Directly Onto Current Consensus Recommendations (2010) (42)
- A multiancestral genome-wide exome array study of Alzheimer disease, frontotemporal dementia, and progressive supranuclear palsy. (2015) (41)
- Use of the CDR® plus NACC FTLD in mild FTLD: Data from the ARTFL/LEFFTDS consortium (2019) (41)
- The utility of apolipoprotein E genotyping in the diagnosis of Alzheimer disease in a community-based case series. (1999) (41)
- Neuropsychiatric symptoms and Apolipoprotein E: Associations with eventual Alzheimer's disease development. (2016) (41)
- Benzodiazepine Use and Cognitive Decline in Elderly With Normal Cognition (2016) (41)
- Conjugal Alzheimer disease: risk in children when both parents have Alzheimer disease. (2008) (41)
- Genetic screening of a large series of North American sporadic and familial frontotemporal dementia cases (2020) (40)
- Sex-specific genetic predictors of Alzheimer’s disease biomarkers (2018) (40)
- Pathogenic Huntingtin Repeat Expansions in Patients with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis (2020) (40)
- Cognitive decline in Alzheimer's disease (1995) (40)
- Intracellular calcium response is reduced in CD4+ lymphocytes in Alzheimer's disease and in older persons with down's syndrome (1993) (40)
- Calcium channel blockers and β-blockers in relation to Parkinson's disease (2007) (40)
- Dichotomous scoring of TDP-43 proteinopathy from specific brain regions in 27 academic research centers: associations with Alzheimer’s disease and cerebrovascular disease pathologies (2018) (39)
- Rarity of the Alzheimer disease-protective APP A673T variant in the United States. (2015) (39)
- Comparison of symptomatic and asymptomatic persons with primary age-related tauopathy (2017) (38)
- Challenges and Considerations Related to Studying Dementia in Blacks/African Americans. (2017) (37)
- Meta-analysis of genetic association with diagnosed Alzheimer’s disease identifies novel risk loci and implicates Abeta, Tau, immunity and lipid processing (2018) (36)
- Differences in rate of functional decline across three dementia types (2013) (36)
- Relationship between serum α1-antichymotrypsin and Alzheimer's disease (1994) (36)
- Clinical and pathologic presentation in Parkinson's disease by apolipoprotein e4 allele status. (2014) (35)
- Association of Long Runs of Homozygosity With Alzheimer Disease Among African American Individuals. (2015) (34)
- Older Adults and Functional Decline: A Cross-Cultural Comparison (2002) (33)
- Global and local ancestry in African-Americans: Implications for Alzheimer's disease risk (2016) (33)
- Impact of sample selection on APOE epsilon 4 allele frequency: a comparison of two Alzheimer's disease samples. (1996) (32)
- Genomics and CSF analyses implicate thyroid hormone in hippocampal sclerosis of aging (2016) (32)
- Developing a global strategy to prevent Alzheimer’s disease: Leon Thal Symposium 2010 (2011) (32)
- Neighborhood built environment and cognition in non-demented older adults: The Multi-Ethnic Study of Atherosclerosis. (2018) (31)
- Rapid Estimation of Hospitalization Charges From a Brief Medical Record Review: Evaluation of a Multivariate Prediction Model (1986) (31)
- Association of TREM2 variants with Alzheimer's disease in African-Americans: For the Alzheimer's Disease Genetics Consortium (ADGC) (2013) (31)
- Individualized atrophy scores predict dementia onset in familial frontotemporal lobar degeneration (2019) (31)
- Future prospects and challenges for Alzheimer's disease drug development in the era of the NIA-AA Research Framework (2018) (30)
- The longitudinal evaluation of familial frontotemporal dementia subjects protocol: Framework and methodology (2019) (30)
- Seizures in Alzheimer’s disease are highly recurrent and associated with a poor disease course (2020) (29)
- Sex-dependent autosomal effects on clinical progression of Alzheimer's disease. (2020) (29)
- Cholinesterase Inhibitors May Not Benefit Mild Cognitive Impairment and Mild Alzheimer Disease Dementia (2019) (28)
- Population Neuroscience: Dementia Epidemiology Serving Precision Medicine and Population Health. (2018) (28)
- Increased platelet membrane fluidity as a diagnostic marker for Alzheimer's disease (1992) (28)
- Theoretical Impact of Florbetapir (18F) Amyloid Imaging on Diagnosis of Alzheimer Dementia and Detection of Preclinical Cortical Amyloid (2014) (28)
- Visual hallucinations in dementia: a prospective community-based study with autopsy. (2009) (27)
- Neuropsychological Markers of Cognitive Decline in Persons With Alzheimer Disease Neuropathology (2015) (27)
- Decreasing hazards of Alzheimer's disease with the use of antidepressants: mitigating the risk of depression and apolipoprotein E (2018) (27)
- Global mortality from dementia: Application of a new method and results from the Global Burden of Disease Study 2019 (2021) (26)
- Cognitive trajectory in mild cognitive impairment due to primary age-related tauopathy. (2020) (26)
- Progression of Alzheimer's disease in black and white patients (1998) (26)
- Author Correction: Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (2019) (26)
- Late-Life Vascular Risk Factors and Alzheimer Disease Neuropathology in Individuals with Normal Cognition (2016) (25)
- Lost in translation: epidemiology, risk, and Alzheimer disease. (2010) (25)
- Clinical and volumetric changes with increasing functional impairment in familial frontotemporal lobar degeneration (2019) (25)
- Risk of dementia and mild cognitive impairment among older adults in same‐sex relationships (2019) (25)
- Differences in Cognitive Impairment in Primary Age-Related Tauopathy Versus Alzheimer Disease (2019) (24)
- Milder Alzheimer's disease pathology in heart failure and atrial fibrillation (2017) (24)
- Mitochondrial Genetic Variants and Alzheimer Disease: A Case-Control Study of the T4336C and G5460A Variants (2002) (24)
- Sudden infant death and infanticide. (1977) (24)
- Active and Passive Cigarette Smoking and Risk of Intracranial Meningioma (2005) (23)
- Mild cognitive impairment in Parkinson's disease versus Alzheimer's disease. (2016) (22)
- Relationship between Cigarette Smoking and Alzheimer's Disease in a Population‐Based Case‐Control Study (1992) (22)
- Are There Clinical and Epidemiological Differences between Familial and Non‐familial Alzheimer's Disease? (1991) (22)
- Comparison of sporadic and familial behavioral variant frontotemporal dementia (FTD) in a North American cohort (2020) (22)
- Calcium channel blockers and beta-blockers in relation to Parkinson's disease. (2007) (21)
- Social Relationships and Risk of Incident Mild Cognitive Impairment in US Alzheimer’s Disease Centers (2014) (21)
- Comparing measures of decline to dementia in amnestic MCI subjects in the National Alzheimer's Coordinating Center (NACC) Uniform Data Set (2012) (20)
- Magnetic resonance imaging brain atrophy assessment in primary age-related tauopathy (PART) (2019) (20)
- Complex interactions underlie racial disparity in the risk of developing Alzheimer's disease dementia (2020) (19)
- Clinical diagnoses among individuals with primary age-related tauopathy versus Alzheimer’s neuropathology (2018) (19)
- Predicting Lewy Body Pathology in a Community-Based Sample With Clinical Diagnosis of Alzheimer’s Disease (2006) (19)
- Enhancing the Power of Genetic Association Studies through the Use of Silver Standard Cases Derived from Electronic Medical Records (2013) (19)
- APOE is a correlate of phenotypic heterogeneity in Alzheimer disease in a national cohort (2019) (19)
- Stroke risk factor knowledge in Hispanic and non-Hispanic white women in New Mexico: implications for targeted prevention strategies. (1998) (18)
- Do cultural differences affect Alzheimer disease? (1996) (18)
- Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH-EXAMINER as a potential clinical trial endpoint (2019) (18)
- Rates of lobar atrophy in asymptomatic MAPT mutation carriers (2019) (18)
- Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH-EXAMINER as a potential clinical trial endpoint (2019) (18)
- Factors Influencing Successful Lumbar Puncture in Alzheimer Research (2017) (17)
- Treated hypothyroidism is associated with cerebrovascular disease but not Alzheimer's disease pathology in older adults (2018) (17)
- Big data, aging, and dementia: Pathways for international harmonization on data sharing (2013) (17)
- Conjugal Alzheimer's disease: Is there an increased risk in offspring? (1993) (16)
- Alzheimer's disease and history of blood transfusion by apolipoprotein-E genotype. (1997) (16)
- The Longitudinal Early‐onset Alzheimer's Disease Study (LEADS): Framework and methodology (2021) (16)
- Anxiety in alzheimer's disease (1999) (15)
- Associations between neighborhood built environment and cognition vary by apolipoprotein E genotype: Multi-Ethnic Study of Atherosclerosis. (2019) (15)
- Mixed neuropathologies and associations with domain-specific cognitive decline (2017) (15)
- Nonlinear Z-score modeling for improved detection of cognitive abnormality (2019) (14)
- Limbic-Predominant Age-Related TDP-43 Encephalopathy (2022) (14)
- Differentiating among stages of cognitive impairment in aging: Version 3 of the Uniform Data Set (UDS) neuropsychological test battery and MoCA index scores (2020) (14)
- Alcohol, Gender, and Cognitive Performance (2004) (14)
- Harmonizing neuropsychological assessment for mild neurocognitive disorders in Europe (2021) (14)
- Tracking white matter degeneration in asymptomatic and symptomatic MAPT mutation carriers (2019) (13)
- Distinguishing Alzheimer's Disease from Other Dementias (1989) (13)
- Episodic memory performance in a multi-ethnic longitudinal study of 13,037 elderly (2018) (13)
- A Cross-Sectional Analysis of Late-Life Cardiovascular Factors and Their Relation to Clinically Defined Neurodegenerative Diseases (2016) (13)
- Sleep in Alzheimer’s Dementia (1987) (12)
- Clinician-judged hearing impairment and associations with neuropathologic burden (2020) (12)
- Brain volumetric deficits in MAPT mutation carriers: a multisite study (2020) (12)
- Relationship of age to incidence of breast cancer in young women. (1976) (12)
- Risk of Decline in Functional Activities in Dementia With Lewy Bodies and Alzheimer Disease (2011) (12)
- Uniform data set language measures for bvFTD and PPA diagnosis and monitoring (2021) (11)
- Role of brain infarcts in behavioral variant frontotemporal dementia Clinicopathological characterization in the National Alzheimer's Coordinating Center database (2015) (11)
- On the uses of registries for Alzheimer disease. (1989) (11)
- Genetic Comparison of Symptomatic and Asymptomatic Persons With Alzheimer Disease Neuropathology (2017) (11)
- Problems in Measuring and Interpreting Cognitive Decline (1998) (11)
- Concordance of Clinical Alzheimer Diagnosis and Neuropathological Features at Autopsy. (2020) (10)
- The Utility of the National Alzheimer’s Coordinating Center’s Database for the Rapid Assessment of Evolving Neuropathologic Conditions (2020) (9)
- The effect of diagnosing Alzheimer’s disease on frequency of physician visits (1995) (9)
- FMNL2 regulates gliovascular interactions and is associated with vascular risk factors and cerebrovascular pathology in Alzheimer’s disease (2022) (9)
- Personalized genetic assessment of age associated Alzheimer’s disease risk (2016) (9)
- The growing global burden of dementia (2006) (9)
- An alternative method for estimating efficacy of the AN1792 vaccine for Alzheimer disease (2007) (9)
- Clinical and Surgical Factors Associated With Increased Epilepsy Risk in Children With Hydrocephalus. (2016) (9)
- The Nevada Vital Aging Initiative: A private-public partnership to study early predictors of dementia (2007) (8)
- Reply: LATE to the PART-y. (2019) (8)
- Relationship between serum alpha 1-antichymotrypsin and Alzheimer's disease. (1994) (8)
- Comparison of Alzheimer’s disease in American Indians, whites, and African Americans (2007) (8)
- Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into the complex genetic architecture (2020) (7)
- Quality of life and caregiver burden in familial frontotemporal lobar degeneration: Analyses of symptomatic and asymptomatic individuals within the LEFFTDS cohort (2020) (7)
- Cognitive Impairment in Older Adults Without Dementia: Clinical and Pathologic Outcomes in a Community-Based Sample (2009) (7)
- Differential Effect of Statins on Risk of AD by Age, Sex, and APOE Genotype: Findings From a Community-based Prospective Cohort Study (2006) (7)
- APOE polymorphisms and late-onset Alzheimer disease: the importance of ethnicity. (1998) (6)
- Divergent magnetic resonance imaging atrophy patterns in Alzheimer's disease and primary age-related tauopathy (2022) (6)
- A Novel Study Paradigm for Long-term Prevention Trials in Alzheimer Disease: The Placebo Group Simulation Approach (PGSA): Application to MCI data from the NACC database. (2014) (6)
- An apple a day to prevent Parkinson disease (2012) (6)
- Anatomical configurations associated with posthemorrhagic hydrocephalus among premature infants with intraventricular hemorrhage. (2016) (6)
- Risk of mild cognitive impairment among older adults in the United States by ethnoracial group (2020) (6)
- Prevention of Alzheimer Disease: A Perspective Based on Successes in the Prevention of Other Chronic Diseases (1996) (6)
- Primary neuropathologic diagnosis and co-occurrence of other neuropathologic features: Results from the National Alzheimer's Coordinating Center (NACC) (2009) (6)
- Trajectories of Cognitive Decline in Brain Donors With Autopsy-Confirmed Alzheimer Disease and Cerebrovascular Disease (2022) (5)
- New thinking about thinking, part two. Theoretical articles for Alzheimer's & Dementia (2018) (5)
- Cross‐sectional differences in symptomatic presentation and cognitive performance among participants with LATE‐NC compared to FTLD‐TDP (2020) (5)
- Interrater Reliability and Accuracy in Identifying Ischemic Strokes Using Computed Tomography Scans in People with Dementia (2005) (5)
- Antithrombotic medication use and dementia incidence among people with mild cognitive impairment and atrial fibrillation (2013) (5)
- Clinically Unsuspected Prion Disease Among Patients With Dementia Diagnoses in an Alzheimer’s Disease Database (2015) (4)
- Factors influencing lumbar puncture participation in Alzheimer’s research (2015) (4)
- Abstracts from Hydrocephalus 2016 (2017) (4)
- Manifestations of Alzheimer’s disease genetic risk in the blood are evident in a multiomic analysis in healthy adults aged 18 to 90 (2022) (4)
- Risk of alzheimer disease is associated with parental age among apolipoprotein E ε4 heterozygotes (1997) (4)
- CHOLINESTERASE INHIBITOR USE AND COGNITIVE DECLINE IN MILD COGNITIVE IMPAIRMENT AND MILD DEMENTIA DUE TO ALZHEIMER DISEASE (2017) (3)
- Sex-dependent polygenic effects on the clinical progressions of Alzheimer’s disease (2019) (3)
- Cognitive domain harmonization and cocalibration in studies of older adults. (2022) (3)
- Effects of Age and Ethnicity on the Link Between APOE ∊4 and Alzheimer Disease—Reply (1998) (3)
- Genetic differences between symptomatic and asymptomatic persons with Alzheimer's disease neuropathologic change (2015) (2)
- COGNITIVE IMPAIRMENT IN PRIMARY AGE-RELATED TAUOPATHY VERSUS ALZHEIMER’S DISEASE (2018) (2)
- THE NATIONAL ALZHEIMER'S COORDINATING CENTER: DEVELOPMENT OF THE MRI, PET AND CSF BIOMARKER DATABASES (2017) (2)
- Factor Consistency of Neuropsychological Test Battery Versions in the NACC Uniform Data Set (2020) (2)
- Neurologic diseases, epidemiology, and public health. (2009) (2)
- THE NATIONAL ALZHEIMER'S COORDINATING CENTER MRI DATABASE (2014) (2)
- Progranulin mutations in clinical and neuropathological Alzheimer's disease (2022) (2)
- NONLINEAR N-SCORE ESTIMATION FOR ESTABLISHING COGNITIVE NORMS FROM THE NATIONAL ALZHEIMER’S COORDINATING CENTER (NACC) DATASET (2018) (2)
- Multiple gene variants linked to Alzheimer’s-type clinical dementia via GWAS are also associated with non-Alzheimer’s neuropathologic entities (2022) (2)
- No protective effect of education in Alzheimer's disease: Findings from the CERAD database (1998) (2)
- Importance of coincident neurodegenerative diseases (2013) (1)
- Association, cause, and causal association, revised: reasoning and methods (2020) (1)
- Consensus diagnosis and predictors of diagnostic accuracy in the national Alzheimer's Disease Centers (2013) (1)
- Erratum: Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report. (Brain (2019) 142, (1503–1527) DOI: 10.1093/brain/awz099) (2019) (1)
- EXPLORING THE LINK BETWEEN HEARING LOSS AND DEMENTIA: IS IMPAIRED HEARING ASSOCIATED WITH COMMON NEUROPATHOLOGIES? (2019) (1)
- The validity of 3 clinical diagnostic criteria for Alzheimer??s disease (1991) (1)
- Multidimensional Complexity in the Dementias: Diagnosis, Stage, Comorbidity, and Neuropsychiatric Symptoms (P07.160) (2012) (1)
- MILD COGNITIVE IMPAIRMENT AMONG PARKINSON'S DISEASE SUBJECTS IN THE UNIFORM DATA SET (2014) (1)
- Are some individuals immune to dementia? (2013) (1)
- Age-dependent effects of APOE e 4 in preclinical Alzheimer’s disease (2016) (1)
- THE NATIONAL ALZHEIMER'S COORDINATING CENTER: DEVELOPMENT OF THE MRI, PET AND CSF BIOMARKER DATABASES (2017) (1)
- Predicting Progression from Normal to MCI and from MCI to AD Using Clinical Variables in the National Alzheimer’s Coordinating Center Uniform Data Set Version 3: Application of Machine Learning Models and a Probability Calculator (2023) (1)
- Symptomatic Profile and Cognitive Performance in Autopsy-Confirmed Limbic-Predominant Age-Related TDP-43 Encephalopathy With Comorbid Alzheimer Disease. (2022) (1)
- The Asian Cohort for Alzheimer’s Disease (ACAD) study (2021) (1)
- Cognitive aging with dementia, mild cognitive impairment (MCI), or no impairment: A comparison of same‐ and other‐sex couples (2021) (1)
- Characteristics and Progress on 312 Subjects in the Longitudinal Evaluation of Familial Frontotemporal Dementia Subjects (LEFFTDS) Protocol (P3.036) (2018) (1)
- Neuropathological lesions and their contribution to dementia and cognitive impairment in a heterogeneous clinical population (2022) (1)
- The Alzheimer's Disease Centers' Neuropsychological Database Initiative: A Resource for Alzheimer's Disease Prevention Trials (2002) (1)
- TRAUMATIC BRAIN INJURY (TBI) AND DEMENTIA PROGRESSION (2016) (1)
- Inaccuracy of the ICD-9-CM in identifying the diagnosis of ischemic cerebrovascular disease (1998) (1)
- AMultiancestral Genome-Wide Exome Array Study of Alzheimer Disease , Frontotemporal Dementia , and Progressive Supranuclear Palsy (2015) (1)
- Validation of the Alzheimer's Prevention Initiative Composite Cognitive Test Score (2013) (1)
- brain human functionally distinct regions of the normal aged Gene expression profiles in anatomically and (2015) (1)
- CHARACTERISTICS AND PROGRESS ON THE INITIAL 209 SUBJECTS IN THE LONGITUDINAL EVALUATION OF FAMILIAL FRONTOTEMPORAL DEMENTIA SUBJECTS (LEFFTDS) PROTOCOL (2017) (1)
- Biomarkers of Alzheimer syndrome and related dementias: A&D author's guide (2022) (1)
- Classification of Stroke Cases in Administrative Data using ICD-9 Codes (2001) (1)
- Is there selection bias in autopsy completion? Results from a community-based study (2000) (1)
- Racial‐ethnic differences in baseline and longitudinal change in neuropsychological test scores in the NACC Uniform Data Set 3.0 (2021) (1)
- Perspectives on shared genetic contributions for Parkinson disease and Alzheimer disease. (2004) (1)
- Symptomatic presentation and cognitive performance in autopsy‐confirmed, limbic‐predominant, age‐related TDP‐43 encephalopathy with comorbid Alzheimer’s disease (2021) (1)
- Risk factors for post-hemorrhagic hydrocephalus among infants with intraventricular hemorrhage (2015) (1)
- P1-256 Age-dependent associations between blood pressure and risk of dementia: A community-based prospective cohort study (2006) (1)
- P2–230: Withdrawn (2013) (0)
- Neuropsychological markers of cognitive decline in persons with Alzheimer’s disease neuropathology (2015) (0)
- APOE4 IS NOT A RISK FACTOR FOR ALZHEIMER’S DISEASE PATHOLOGY IN PPA, IRRESPECTIVE OF CLINICAL SUBTYPE (2018) (0)
- Sex‐specific genetic predictors of memory performance (2021) (0)
- VALIDATING THE PLACEBO GROUP SIMULATION APPROACH (PGSA): AN ALTERNATIVE STUDY DESIGN FOR PREVENTIVE TRIALS IN PRODROMAL AD PATIENTS (2014) (0)
- Predicting Conversions from Normal to MCI and from MCI to AD with Clinical Variables in the National Alzheimer’s Coordinating Center Uniform Data Set Version 3: Application of Big Data Analytics and Transition Probability Calculators (2022) (0)
- Portuguese version of the CDR plus NACC FTLD: Validation studies (2022) (0)
- List of contributors. (2019) (0)
- Platelet membrane fluidity (1993) (0)
- Memory clinics as vehicles of research into dementia: The NACC example (2020) (0)
- Population-based analysis of medical complications and length of stay in patients hospitalized for ischemic stroke (1997) (0)
- TRACKING WHITE MATTER DEGENERATION IN ASYMPTOMATIC AND SYMPTOMATIC MAPT MUTATION CARRIERS WITH DTI (2019) (0)
- PREVALENCE OF MILD COGNITIVE IMPAIRMENT IN APOE ε3/ε3 INDIVIDUALS WITH A FAMILY HISTORY OF ALZHEIMER’S DISEASE (2019) (0)
- RHEUMATOID ARTHRITIS, INFLAMMATION TREATMENT, AND ALZHEIMER’S DISEASE: A CROSS-SECTIONAL DESCRIPTIVE STUDY USING THE NACC DATABASE (2018) (0)
- Studying the natural history of frontotemporal lobar degeneration (FTLD): The ARTFL LEFFTDS longitudinal FTLD (ALLFTD) protocol (2020) (0)
- Neuropathological diagnoses in a community-based incident dementia case series (2000) (0)
- P4-083 RACIAL DIFFERENCES OF INCIDENT ALZHEIMER’S DISEASE AS A FUNCTION OFAPOE4 (2018) (0)
- Alzheimer Disease candidate variants are associated with cerebral amyloid angiopathy (2022) (0)
- Clinical features that differentiate young‐onset AD from young‐onset FTLD: An examination of the NACC UDS 3.0 and FTLD Module (2021) (0)
- THE NATIONAL ALZHEIMER'S COORDINATING CENTER: QUERYING THE DATABASE AND REQUESTING DATA (2017) (0)
- Genetic Data Identify Dual‐enrolled Participants in Alzheimer's Disease and Related Dementia (ADRD) Studies (2022) (0)
- P3-117 Statin therapy and risk of dementia in the elderly: a community-based prospective cohort study (2004) (0)
- Epidemiology, Risk, and Alzheimer Disease (2016) (0)
- MULTIPLE FACTOR ANALYSIS OF NEUROPSYCHOLOGICAL TEST BATTERY CHANGE IN THE NATIONAL ALZHEIMER’S COORDINATING CENTER UNIFORM DATA SET (2019) (0)
- Neuropsychiatric abnormalities in familial frontotemporal dementia: Findings from the LEFFTDS Cohort (2020) (0)
- CLINICAL PROGRESSION IN MIXED NEUROPATHOLOGIES: TESTING INTERACTIONS OF LEWY BODIES AND VASCULAR BRAIN INJURY WITH ALZHEIMER'S DISEASE NEUROPATHOLOGIC CHANGE (2016) (0)
- Family history and apoE genotype interaction in Alzheimer`s disease (AD) (1994) (0)
- Longitudinal changes in FAQ scores by informant relationship (2020) (0)
- Pulse pressure and atherosclerosis, arteriolosclerosis and cortical microinfarcts in individuals with clinical Alzheimer's disease (2013) (0)
- Cluster analysis of neuropathologic features in the National Alzheimer’s Coordinating Center data set (2021) (0)
- On the Uses of Regisries for Alzheimer Disease (1989) (0)
- FMNL2 interacts with cerebrovascular risk factors to alter Alzheimer's disease risk (2020) (0)
- Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity (2020) (0)
- Erratum (1979) (0)
- The trajectory of cognitive decline and neuropathological features among APOEɛ2 carriers (2020) (0)
- ASSOCIATIONS OF NEUROPATHOLOGY AND APOLIPOPROTEIN E GENOTYPE WITH DEMENTIA IN THE OLDEST-OLD COMPARED TO YOUNGER-OLD AGE GROUPS (2017) (0)
- Educational Attainment in Patients with Frontotemporal Dementia and Primary Progressive Aphasia Compared to Other Dementia Syndromes (P03.089) (2013) (0)
- CARDIOVASCULAR RISK FACTORS AND THEIR INTERACTIONS AMONG CLINICALLY DEFINED NEURODEGENERATIVE DISEASES (2014) (0)
- Genome-wide structural variant analysis identifies risk loci for non-Alzheimer’s dementias (2023) (0)
- Elucidating Subtypes and Risk Factors of Brain Arteriolosclerosis (P1.195) (2018) (0)
- ADVANCING RESEARCH AND TREATMENT IN FRONTOTEMPORAL LOBAR DEGENERATION (ARTFL) NORTH AMERICAN RARE DISEASE CLINICAL RESEARCH CONSORTIUM: PROGRESS AND CHARACTERIZATION OF INITIAL PARTICIPANTS (2017) (0)
- CHARACTERISTICS AND PROGRESS OF 320 SUBJECTS IN THE LONGITUDINAL EVALUATION OF FAMILIAL FRONTOTEMPORAL DEMENTIA SUBJECTS (LEFFTDS) PROTOCOL (2018) (0)
- The NACC uniform data set (2010) (0)
- EPILEPSY IN ALZHEIMER DISEASE IS FREQUENT AND CHARACTERIZED BY HIGH RECURRENCE (2019) (0)
- Risk factors for post-hemorrhagic hydrocephalus among infants with intraventricular hemorrhage (2015) (0)
- P3-166 Lewy body pathology in a large, autopsy confirmed, community-based dementia sample (2004) (0)
- Family history, demographics, and genetic characteristics of symptomatic and non-symptomatic subjects with neuropathological Alzheimer's disease in the National Alzheimer's Coordinating Center (NACC) datasets (2010) (0)
- P4-023 Depression within dementia subtypes: data from the national Alzheimer's coordinating center (2004) (0)
- Cholinesterase inhibitors and memantine use in the National Alzheimer's Coordinating Center's Uniform Data Set: A longitudinal assessment of real-world medication use in dementia (2012) (0)
- Title Age-dependent effects of APOE epsilon 4 in preclinical Alzheimer ' s disease (2016) (0)
- Comparing Global measures of cognitive decline in amnestic mci subjects in the National Alzheimer's Coordinating Center (NACC) uniform data set (2011) (0)
- Physician visit frequency in Alzheimer’s disease (1995) (0)
- THE NATIONAL ALZHEIMER'S COORDINATING CENTER MRI DATABASE (2014) (0)
- PHENOCONVERSION FROM ASYMPTOMATIC TO MINIMALLY SYMPTOMATIC FTLD: PRELIMINARY DATA IN THE LEFFTDS COHORT (2017) (0)
- RACIAL DIFFERENCES OF INCIDENT ALZHEIMER’S DISEASE AS A FUNCTION OF APOE4 (2018) (0)
- Comparison of neuropsychological test scores among English and Spanish speakers in a multi-regional sample of cognitively normal subjects (2012) (0)
- EFFECTS OF AGE AND ETHNICITY ON THE LINK BETWEEN APOE EPSILON 4 AND ALZHEIMER DISEASE. AUTHORS' REPLY (1998) (0)
- Contents (2009) (0)
- New data gathering, instrument selection, and evaluation of existing information for determining entry (1990) (0)
- Gearing up for the future: Exploring facilitators and barriers to inform clinical trial design in frontotemporal lobar degeneration (2021) (0)
- TRAJECTORY OF NEUROPSYCHOLOGICAL TEST SCORES IN MILD COGNITIVE IMPAIRMENT COMPARING PRIMARY AGE-RELATED TAUOPATHY VERSUS ALZHEIMER DISEASE (2019) (0)
- DIFFERENCES BETWEEN SPORADIC AND FAMILIAL BEHAVIORAL VARIANT FTD IN ADVANCING RESEARCH AND TREATMENT FOR FTLD (ARTFL) CLINICAL RESEARCH CONSORTIUM (2018) (0)
- Neuropathological Influences on the Clinical Phenotype of Synucleinopathies (P6.225) (2016) (0)
- Alzheimer’s Disease and the Search for Environmental Risk Factors (2015) (0)
- P3-190 Lewy Body (LB) pathology and clinical diagnoses in the National Alzheimer’s Coordinating Center (NACC) database (2006) (0)
- FRONTOTEMPORAL LOBAR DEGENERATION RESEARCH IN NORTH AMERICA: PROGRESS IN THE ARTFL/LEFFTDS CONSORTIA (2019) (0)
- Magnetic resonance imaging brain atrophy assessment in primary age-related tauopathy (PART) (2019) (0)
- NEUROPATHOLOGICAL FEATURES IN PARTICIPANTS WITH SLEEP DISORDERS: A CROSS-SECTIONAL DESCRIPTIVE STUDY USING THE NACC DATABASE (2019) (0)
- DISPARITIES IN THE COGNITIVE TRAJECTORY OF LATINO MCI PARTICIPANTS: AN ANALYSIS OF THE NACC DATABASE (2019) (0)
- LATENT ANALYSIS OF EXTRAPYRAMIDAL SIGNS IN ALZHEIMER'S DISEASE IDENTIFIES DISTINCT DISEASE EXPRESSIONS (2014) (0)
- Cerebral amyloid angiopathy and its co-occurrence with Alzheimer's disease in the National Alzheimer's Coordinating Center Neuropathology data set (2013) (0)
- Human Responses to Cancer (1984) (0)
- Featured Article Multisite assessment of NIA-AA guidelines for the neuropathologic evaluation of Alzheimer's disease (2016) (0)
- Longitudinal GWAS Identifies Novel Genetic Variants and Complex Traits Associated with Resilience to Alzheimer’s Disease (2022) (0)
- P2-117 The national Alzheimer’s coordinating center’s data submission system and database (2006) (0)
- Acta Neuropathologica ABCC 9 gene polymorphism is associated with hippocampal sclerosis of aging pathology (2017) (0)
- Cognitive performance among participants with Alzheimer’s disease and cerebral amyloid angiopathy (2020) (0)
- Sex‐specific genetic predictors of memory, executive function, and language performance (2022) (0)
- Multimodal genome‐wide meta‐analysis of brain amyloidosis reveals heterogeneity across CSF, PET, and pathological amyloid measures (2020) (0)
- Aging 6-2019 Limbic-Predominant Age-Related TDP-43 Encephalopathy ( LATE ) : Consensus Working Group Report (2019) (0)
- LONGITUDINAL COGNITIVE PERFORMANCE IN PARTICIPANTS WITH MILD COGNITIVE IMPAIRMENT AND IMPAIRED AWARENESS OF DECLINE (2019) (0)
- Accuracy of the Clinical Diagnosis of Alzheimer Disease at National Institute on Aging Alzheimer Disease Centers, 2005Y2010 (2012) (0)
- INCIDENCE OF DEMENTIA SUBTYPES IN A COMMUNITY-BASED PROSPECTIVE COHORT STUDY: THE ADULT CHANGES IN THOUGHT (ACT) STUDY (2016) (0)
- The status of digital pathology and machine learning within Alzheimer’s Disease Centers (2020) (0)
- Abstracts from Hydrocephalus 2016 (2017) (0)
- Neuropsychiatric symptoms in mild Alzheimer's disease: The influence of research study informants (2012) (0)
- Exceptionally low likelihood of Alzheimer’s dementia in APOE2 homozygotes from a 5,000-person neuropathological study (2020) (0)
- THE CLINICAL SPECTRUM OF FRONTOTEMPORAL LOBAR DEGENERATION IN NORTH AMERICA: BASELINE CHARACTERISTICS OF THE FIRST 912 PARTICIPANTS FROM THE ADVANCING RESEARCH AND TREATMENT IN FTLD (ARTFL) CLINICAL RESEARCH CONSORTIUM (2018) (0)
- AFRICAN AMERICAN BRAIN AUTOPSIES FROM THE NATIONAL ALZHEIMER’S COORDINATING CENTER (2016) (0)
- P1-497 CLINICAL CORRELATES OF LEWY BODY PATHOLOGY IN AUTOSOMAL DOMINANT ALZHEIMER DISEASE OPHTHALMOLOGY-BASED AD RISK FACTORS: DIABETIC RETINOPATHY IS ASSOCIATED WITH DEEP MICROINFARCTS IN A COMMUNITY-BASED AUTOPSY STUDY PRIMARYAGE-RELATED TAUOPATHY VERSUS ALZHEIMER’S NEUROPATHOLOGY (2018) (0)
- APOE-ɛ4 and clinical progression in Parkinson's disease (2013) (0)
- PLASMA AMYLOID, INFLAMMATORY MARKERS, AND TIME TO DEMENTIA IN THE GINKGO EVALUATION OF MEMORY STUDY (2019) (0)
- enzyme-linked immunosorbent NONLINEAR N-SCORE ESTIMATION FOR ESTABLISHING COGNITIVE NORMS FROM (2018) (0)
- Aluminum , Drinking Water , and Alzheimer ' s Disease [ Project (2010) (0)
- Neurological diseases, epidemiology, and public health (2021) (0)
- GRAY MATTER DEFICITS IN SYMPTOMATIC AND PRESYMPTOMATIC MAPT MUTATION CARRIERS (2018) (0)
- Statin therapy and risk of dementia in the elderly [4] (multiple letters) (2005) (0)
- The Asian Cohort for Alzheimer’s Disease (ACAD) Pilot Study (2022) (0)
- Development of harmonized and co‐calibrated scores for memory, executive functioning, language, and visuospatial in the AIBL Study, ADNI, and NACC datasets (2022) (0)
- THE MULTIDOMAIN IMPAIRMENT RATING (MIR) SCALE: INITIAL RELIABILITY DATA ON A MULTIDIMENSIONAL SCALE DESIGNED FOR FTLD SPECTRUM DISORDERS (2019) (0)
- P3-110 Public-use data from NACC (2004) (0)
- Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (2019) (0)
- ASSOCIATION BETWEEN ANTIDEPRESSANT USE AND INCIDENT MCI IN OLDER ADULTS WITH DEPRESSION (2017) (0)
- Similar maximal educational attainment in people with dementia: Association with pathologically diagnosed frontotemporal lobar degeneration, Alzheimer's disease and Lewy body disease? (2013) (0)
- Cognitive Aging with Dementia, Mild Cognitive Impairment, or No Impairment: A Comparison of Same- and Mixed-Sex Couples. (2023) (0)
- P1-112 Neuropsychological characterization of dementia with Lewy bodies in a community-based, autopsy sample of dementia (2004) (0)
- Sex differences in APOE effects on cognition are domain‐specific (2022) (0)
- Differentiating among stages of cognitive impairment: Comparisons of versions two and three of the National Alzheimer’s Coordinating Center (NACC) Uniform Data Set (UDS) neuropsychological test battery (2020) (0)
- Impact of time-scale choice on rate of cognitive decline: A case study from the national Alzheimer’s coordinating center minimum data set (2005) (0)
- Sex differences in rate of progression of three dementia types (2012) (0)
- O1-04-07 ″Amygdala predominant″ Lewy body disease: A subtype of Alzheimer’s disease with a more aggressive clinical course (2006) (0)
- APOE4 NON-CARRIERS WITH THE CLINICAL DIAGNOSIS OF ALZHEIMER'S DEMENTIA AND MINIMAL AMYLOID HISTOPATHOLOGY (2014) (0)
- by flavonoids An apple a day to prevent Parkinson disease : Reduction of risk (2012) (0)
- P-169 Association between statins and risk of AD is age dependent (2007) (0)
- Genetically elevated high-density lipoprotein cholesterol through the cholesteryl ester transfer protein gene does not associate with risk of Alzheimer's disease (2018) (0)
- THE NIH-EXAMINER IS SENSITIVE TO COGNITIVE CHANGES IN ASYMPTOMATIC AND MILDLY SYMPTOMATIC FAMILIAL FRONTOTEMPORAL DEMENTIA (2018) (0)
- INCIDENT DEMENTIA IN NON-HISPANIC AFRICAN AMERICANS AND WHITES WITH MILD COGNITIVE IMPAIRMENT: CAN WE MAKE RACIAL COMPARISONS USING ALZHEIMER’S DISEASE CENTER DATA? (2018) (0)
- Comparison of clinical and neuropathological definitions of alzheimer's disease at national institute on aging Alzheimer's disease centers, 2005-2010 (2011) (0)
- P1-136 Examining the agreement between CERAD and NIA/Reagan Institute neuropathological criteria for the diagnosis of Alzheimer's disease (2004) (0)
- Dichotomous scoring of TDP-43 proteinopathy from specific brain regions in 27 academic research centers: associations with Alzheimer’s disease and cerebrovascular disease pathologies (2018) (0)
- Association, Cause and Causal Association (2014) (0)
- Web-based Data Quality Assurance Reports at the National Alzheimer's Coordinating Center (NACC) (2007) (0)
- RISK FACTORS FOR CLINICAL AD IN U.S. LATINO POPULATIONS: AN ANALYSIS OF THE NACC DATABASE (2018) (0)
- USING A BRAIN NETWORK APPROACH TO PREDICT GENETIC MUTATION IN INDIVIDUAL PATIENTS WITH FAMILIAL FRONTOTEMPORAL DEMENTIA (2018) (0)
- Commentary on “A roadmap for the prevention of dementia II: Leon Thal Symposium 2008.” “Big Asks”: What can be changed to increase and speed progress on Alzheimer's disease research and treatment? (2009) (0)
- The status of digital pathology and associated infrastructure within Alzheimer’s Disease Centers (2023) (0)
- Genome‐wide interaction study of smoking in Alzheimer’s disease (2020) (0)
- Does hypertension affect the risk and age at onset of Alzheimer disease? (2000) (0)
- Vascular neuropathology in dementia patients receiving antipsychotic therapy (2013) (0)
- DEMENTIA DIAGNOSES, NEUROPSYCHIATRIC SYMPTOMS AND PHYSICAL COMORBIDITIES (2012) (0)
- THE CONTRIBUTION OF SEX-SPECIFIC ASSOCIATIONS IN GENETIC STUDIES OF ALZHEIMER’S DISEASE PATHOLOGY (2018) (0)
- associated Alzheimer disease risk : Development and validation of a polygenic hazard score Permalink (2017) (0)
- THE NATIONAL ALZHEIMER'S COORDINATING CENTER: QUERYING THE DATABASE AND REQUESTING DATA (2017) (0)
- Clinic‐based data serving Population Neuroscience: NACC example (2021) (0)
- Hippocampal sclerosis of aging, a key potential Alzheimer’s disease confounder: The NACC experience (2013) (0)
- Adverse drug reactions associated with global cognitive impairment in elderly persons (1988) (0)
- PULSE PRESSURE IN LATE-LIFE AND ALZHEIMER’S AND CEREBROVASCULAR NEUROPATHOLOGY (2017) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Walter A. Kukull?
Walter A. Kukull is affiliated with the following schools: